Sera Prognostics, Inc. (SERA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.07
+3.25%
Mkt Cap $72.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $31.77K | $10.00K | -68.52% | -$0.17 | -$0.16 | +5.88% | — | — |
| Q4 2025 Nov 13, 2025 | $50.35K | $16.00K | -68.22% | -$0.19 | -$0.16 | +15.79% | — | — |
| Q3 2025 Aug 6, 2025 | $150.00K | $17.00K | -88.67% | -$0.21 | -$0.16 | +23.81% | — | — |
| Q2 2025 May 7, 2025 | $50.00K | $38.00K | -24.00% | -$0.24 | -$0.20 | +16.67% | — | — |
| Q1 2025 Mar 19, 2025 | $14.50K | $24.00K | +65.52% | -$0.23 | -$0.25 | -8.70% | — | — |
| Q4 2024 Nov 6, 2024 | $86.90K | $29.00K | -66.63% | -$0.22 | -$0.24 | -9.09% | — | — |
| Q3 2024 Aug 7, 2024 | $80.00K | $24.00K | -70.00% | -$0.23 | -$0.25 | -8.70% | — | — |
| Q2 2024 May 8, 2024 | $65.75K | $39.00K | -40.68% | -$0.23 | -$0.25 | -8.70% | — | — |
| Q1 2024 Mar 20, 2024 | $93.70K | $41.00K | -56.24% | -$0.25 | -$0.25 | +0.00% | — | — |
| Q4 2023 Nov 8, 2023 | $99.20K | $42.00K | -57.66% | -$0.30 | -$0.23 | +23.33% | — | — |
| Q3 2023 Aug 9, 2023 | $122.60K | $123.00K | +0.33% | -$0.34 | -$0.34 | +0.00% | — | — |
| Q2 2023 May 10, 2023 | $100.00K | $100.00K | +0.00% | -$0.35 | -$0.34 | +2.86% | — | — |
| Q1 2023 Mar 22, 2023 | $133.33K | $65.00K | -51.25% | -$0.42 | -$0.31 | +26.19% | — | — |
| Q4 2022 Nov 9, 2022 | $110.00K | $87.00K | -20.91% | -$0.40 | -$0.35 | +12.50% | — | — |
| Q3 2022 Aug 10, 2022 | $100.00K | $78.00K | -22.00% | -$0.40 | -$0.37 | +7.50% | — | — |
| Q2 2022 May 10, 2022 | $66.67K | $38.00K | -43.00% | -$0.34 | -$0.40 | -17.65% | — | — |
| Q1 2022 Mar 29, 2022 | $133.33K | $26.00K | -80.50% | -$0.29 | -$0.41 | -41.38% | — | — |
| Q4 2021 Nov 9, 2021 | $19.40K | $23.00K | +18.54% | -$0.22 | -$0.39 | -77.27% | — | — |
| Q3 2021 Aug 30, 2021 | $281.00K | $20.00K | -92.88% | -$1.26 | -$3.17 | -151.59% | — | — |
| Q3 2021 Jul 16, 2021 | — | $13.00K | — | — | -$0.21 | — | — | — |